These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 23015721)
1. Intersubtype differences in the effect of a rare p24 gag mutation on HIV-1 replicative fitness. Chopera DR; Cotton LA; Zawaira A; Mann JK; Ngandu NK; Ntale R; Carlson JM; Mlisana K; Woodman Z; de Assis Rosa D; Martin E; Miura T; Pereyra F; Walker BD; Gray CM; Martin DP; Ndung'u T; Brockman MA; Karim SA; Brumme ZL; Williamson C; J Virol; 2012 Dec; 86(24):13423-33. PubMed ID: 23015721 [TBL] [Abstract][Full Text] [Related]
2. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity. Tsai MC; Singh S; Adland E; Goulder P J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820 [TBL] [Abstract][Full Text] [Related]
3. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function. Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081 [TBL] [Abstract][Full Text] [Related]
4. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. Martinez-Picado J; Prado JG; Fry EE; Pfafferott K; Leslie A; Chetty S; Thobakgale C; Honeyborne I; Crawford H; Matthews P; Pillay T; Rousseau C; Mullins JI; Brander C; Walker BD; Stuart DI; Kiepiela P; Goulder P J Virol; 2006 Apr; 80(7):3617-23. PubMed ID: 16537629 [TBL] [Abstract][Full Text] [Related]
5. Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity. Wright JK; Naidoo VL; Brumme ZL; Prince JL; Claiborne DT; Goulder PJ; Brockman MA; Hunter E; Ndung'u T J Virol; 2012 Mar; 86(6):3193-9. PubMed ID: 22238317 [TBL] [Abstract][Full Text] [Related]
6. Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression. Kiguoya MW; Mann JK; Chopera D; Gounder K; Lee GQ; Hunt PW; Martin JN; Ball TB; Kimani J; Brumme ZL; Brockman MA; Ndung'u T J Virol; 2017 Jul; 91(13):. PubMed ID: 28424286 [TBL] [Abstract][Full Text] [Related]
7. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters. Wright JK; Brumme ZL; Carlson JM; Heckerman D; Kadie CM; Brumme CJ; Wang B; Losina E; Miura T; Chonco F; van der Stok M; Mncube Z; Bishop K; Goulder PJ; Walker BD; Brockman MA; Ndung'u T J Virol; 2010 Oct; 84(20):10820-31. PubMed ID: 20702636 [TBL] [Abstract][Full Text] [Related]
8. Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgrounds. Liu Y; Rao U; McClure J; Konopa P; Manocheewa S; Kim M; Chen L; Troyer RM; Tebit DM; Holte S; Arts EJ; Mullins JI PLoS One; 2014; 9(4):e94240. PubMed ID: 24713822 [TBL] [Abstract][Full Text] [Related]
9. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731 [TBL] [Abstract][Full Text] [Related]
10. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations. Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617 [TBL] [Abstract][Full Text] [Related]
11. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection. Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209 [TBL] [Abstract][Full Text] [Related]
12. Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression. Ntale RS; Chopera DR; Ngandu NK; Assis de Rosa D; Zembe L; Gamieldien H; Mlotshwa M; Werner L; Woodman Z; Mlisana K; Abdool Karim S; Gray CM; Williamson C; J Virol; 2012 Nov; 86(22):12013-24. PubMed ID: 22933291 [TBL] [Abstract][Full Text] [Related]
13. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals. Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907 [TBL] [Abstract][Full Text] [Related]
14. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631 [TBL] [Abstract][Full Text] [Related]
15. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes. Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R mBio; 2017 Nov; 8(6):. PubMed ID: 29184023 [TBL] [Abstract][Full Text] [Related]
16. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. Troyer RM; McNevin J; Liu Y; Zhang SC; Krizan RW; Abraha A; Tebit DM; Zhao H; Avila S; Lobritz MA; McElrath MJ; Le Gall S; Mullins JI; Arts EJ PLoS Pathog; 2009 Apr; 5(4):e1000365. PubMed ID: 19343217 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness. Sanchez-Merino V; Farrow MA; Brewster F; Somasundaran M; Luzuriaga K J Infect Dis; 2008 Jan; 197(2):300-8. PubMed ID: 18177249 [TBL] [Abstract][Full Text] [Related]
18. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient. Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738 [TBL] [Abstract][Full Text] [Related]
19. Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity. Naidoo VL; Mann JK; Noble C; Adland E; Carlson JM; Thomas J; Brumme CJ; Thobakgale-Tshabalala CF; Brumme ZL; Brockman MA; Goulder PJR; Ndung'u T J Virol; 2017 Sep; 91(17):. PubMed ID: 28637761 [TBL] [Abstract][Full Text] [Related]
20. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]